Slide CordenPharma scientist in lab coat holding binder for News & Press header with white global connectivity background

NEWS & PRESS


News

September 13, 2022

CDMO CEO Strategy to Grow Stronger Through Flexibility, Creativity & Resilience

Sept 13, 2022
PHARMAnetwork Interviews Dr. Michael Quirmbach in 2022 CDMO CEO Visions & Strategies Issue.
August 11, 2022

Mini-Tablet Dose Form Considerations for Pediatric Patients

August 11, 2022
PMPS Article > Dr. Brittany Hayes discusses mini-tablet dose form development considerations for pediatric patients.
July 15, 2022

Risk-based Process Design & Control Technologies Key to Cost-efficient Sterile Injectable Manufacturing

July 4, 2022
Manufacturing Chemist Article: Fabio Stevanon gives keys to cost-efficient sterile injectable manufacturing.
July 6, 2022

C&EN: Eiger and CordenPharma Bring Orphan Drug for Progeria to Market

July 1, 2022
C&EN Article: Eiger & CordenPharma Bring Orphan Drug Zokinvy (Lonafarnib) for Rare Disease Progeria to Market
June 8, 2022

World Pharma Today: Solid Dose Pharmaceuticals to Remain Strong

June 8, 2022
World Pharma Today Interview: Dr. Brittany Hayes talks trends & strategy of Oral Solid Dose (OSD) manufacturing.
April 13, 2022

CordenPharma Receives Supplier Recognition Award from Esperion

April 13, 2022
CordenPharma Receives Supplier Recognition Award from Esperion at DCAT Week 2022.
March 10, 2022

CordenPharma Donates to Support Disaster Relief Efforts in the Ukraine

March 10, 2022
CordenPharma donates a combined €100,000 to support disaster relief efforts in the Ukraine.
March 3, 2022

CEO Michael Quirmbach Talks Expanded Footprint, Green Chemistry & Growth

March 3, 2022
Global Business Reports Interview: CEO Michael Quirmbach Talks 2022 Expanded Footprint & Growth Strategy
January 13, 2022

DCAT Value Chain Insights Interviews CEO Michael Quirmbach on 2022 CDMO Key Issues

January 13, 2021
DCAT Value Chain Insights Interview: CEO Michael Quirmbach Talks Trends & Issues in the CDMO Sector for 2022.
January 1, 2022

CordenPharma COVID-19 Customer Letter

Jan 1, 2022
COVID-19 > Read CEO Dr. Michael Quirmbach's Customer Letter Response to COVID-19.
November 23, 2021

CordenPharma Chenôve Attracts Top Talent in The Pharmaceutical Industry

November 23, 2021
Interview with CordenPharma Chenôve, Yves Michon, Managing Director
October 18, 2021

CordenPharma 15 Year Anniversary

Edition 3 / October 2021
CordenPharma 15 Year Anniversary > Celebrating on CordenPharma Day - October 1, 2021
June 23, 2021

CEO Michael Quirmbach Talks New Funding & Importance of CDMO End-to-End Services

June 23, 2021
Global Business Reports Interview: CEO Michael Quirmbach Talks Funding & CDMO End-to-End Services
April 28, 2021

When the EU’s Covid-19 Vaccine Drive Stumbled, It Turned to Mr. Fixit

April 28, 2021
> Wall Street Journal: When the EU’s Covid-19 Vaccine Drive Stumbled, It Turned to Mr. Fixit
April 21, 2021

Vaccine: Dr. Clemens Horn, The Magician Chemist of CordenPharma

April 21, 2021
Vaccine: Dr. Clemens Horn, The Magician Chemist of CordenPharma